Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
152.43
-0.45 (-0.29%)
Sep 3, 2025, 4:00 PM - Market closed
Zoetis Revenue
Zoetis had revenue of $2.46B in the quarter ending June 30, 2025, with 4.19% growth. This brings the company's revenue in the last twelve months to $9.39B, up 5.27% year-over-year. In the year 2024, Zoetis had annual revenue of $9.26B with 8.33% growth.
Revenue (ttm)
$9.39B
Revenue Growth
+5.27%
P/S Ratio
7.29
Revenue / Employee
$680,072
Employees
13,800
Market Cap
67.55B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ZTS News
- 3 days ago - Zoetis: A Solid Dividend Growth Investment For The Long Haul - Seeking Alpha
- 8 days ago - Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Business Wire
- 10 days ago - Zoetis: Why I Decided To Invest In The Stock - Seeking Alpha
- 23 days ago - Zoetis Announces Pricing of $1.85 Billion of Senior Notes - Business Wire
- 4 weeks ago - Top 50 High-Quality Dividend Stocks For August 2025 - Seeking Alpha
- 4 weeks ago - Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline - Benzinga
- 4 weeks ago - Animal healthcare firm Zoetis raises annual forecast on strong pet product demand - Reuters